We're all set for a new experience. To visit the old Ventura website, click here.
Ventura Wealth Clients Login here

NSEBSE
NSEBSE
noteThere is a 15-minute delay in the prices. To check out the live prices, log in to your Ventura account or open one today.
1D
1W
1M
1Y
3Y
5Y
Max
Open2,559.2
High2,619.9
Low2,551.9
Prev. Close2,586.4
Avg. Traded Price2,586.08
Volume64,119

MARKET DEPTH

info2
Total bid0.00
Total ask275.00
OrdersQtyBid
000
000
000
000
000
AskQtyOrders
2586.44275
000
000
000
000

HIGH/LOW

info2
1d
1w
1m
3m
52w

LOW/HIGH

2,551.9013 hours ago
2,619.9013 hours ago
arrow

LOWER/UPPER CIRCUITS

2,047.40
3,071.00
arrow
Ajanta Pharma Ltd Stock performance
arrow

KEY OBSERVATIONS

info
positive
negative
neutral
noteAnnual Revenue,rose 10.46%, in the last year to ₹4,742.6 Cr. Its sector's average revenue growth for the last fiscal year was 9.91%.
noteAnnual Net Profit,rose 12.77% in the last year to ₹920.39 Cr. Its sector's average net profit growth for the last fiscal year was 34.87%.
notePrice to Earning Ratio,is 34.73, lower than its sector PE ratio of 41.55.
View more

LONG-TERM PRICE ANALYSIS

info
Stock return5Y CAGR : 26.45%
Net profit growth 5Y CAGR : 16.1%
Ajanta Pharma Ltd Top mutual funds holding
arrow
Ajanta Pharma Limited is a specialty pharmaceuticals formulation company with a well-diversified Branded Generics business spread across India, the rest of Asia, and Africa. The company has a strong chronic-focused product portfolio led by a first-to-market strategy and front-end presence which helps it outgrow the market. The company is committed to investing in innovative products to fill identified gaps and putting major capital allocation into this business. Ajanta’s business also consists of two more verticals: US Generics and Institutional business in Africa.
personal

Grow your wealth with more research recommendations

+91